NPR News & Classical Music
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
News

Jury Selection Begins In Martin Shkreli Fraud Case

shkreli_apsethwenig_170626.jpg
Seth Wenig
/
AP
Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York on Monday.

Jury selection has begun for the pharmaceutical businessman Martin Shkreli. He is defending charges that he stole money from one of his companies to cover the lies that he made to investors of another company he owns. Despite a possible 20 years in prison, Shkreli has not kept quiet.

Shkerli’s notoriety stems from raising the price of a lifesaving medicine by 5,000 percent – also harassing journalists, provoking conspiracy theories, and flaunting expensive purchases. None of which he is on trial for.

Instead, federal prosecutors say he ran two Ponzi-like schemes in order to settle personal and business debts. Despite the accusations, he has kept a steady stream of taunting and profane social media posts.

Columbia University Law Professor John Coffee says, “You’re seeing a defendant who is using this as his own personal theater. It may be therapeutic, but it could be very expensive if he is convicted.”

Shkeri’s legal team tried unsuccessfully to bar the media from covering the trial for fear it would taint the jury’s verdict.